SRDX250516C40000
- 0.05
- 0.000.00%
SurModics Newsroom
SurModics Down Over 8%, On Track for Largest Percent Decrease Since March 2023 -- Data Talk
Surmodics Shares Are Trading Lower. The Company Reported Q2 Financial Results and Issued FY25 Guidance Below Estimates.
Express News | Surmodics Shares Are Trading Lower. The Company Reported Q2 Financial Results and Issued FY25 Guidance Below Estimates
Express News | Needham Reiterates Hold on Surmodicsto Hold
Surmodics Analyst Ratings
SurModics | 10-Q: Quarterly report
Surmodics Sees FY25 EPS (62c)-(42c), Consensus (26c)
Express News | Surmodics Tariff Exposure Related to Supply Chain Represents Modest Percentage of Total Product Sales
Express News | Surmodics Expects FY25 Financial Guidance Does Not Reflect Possible Tariff Impacts
Express News | Surmodics Expects FY25 Financial Performance to Remain Impacted by Lower Surveil Dcb License Fee, Product Revenue
SurModics: Fiscal Q2 Earnings Snapshot
Express News | Surmodics Sees FY2025 GAAP EPS $(1.60)-$(1.40) Vs $(0.61) Est
Express News | Surmodics Sees FY2025 Adj EPS $(0.62)-$(0.42) Vs $(0.37) Est; Sees Sales $114.000M-$117.000M Vs $127.27M Est
SurModics | 8-K: Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
Express News | Surmodics Q2 Basic EPS USD -0.36
Express News | Surmodics Outlook FY Revenue USD 114-117 Million
Express News | Surmodics Q2 Product Sales USD 14.993 Million
Press Release: Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
Surmodics 2Q Loss $5.21M >SRDX
Earnings Preview: SurModics to Report Financial Results Pre-market on April 30